The Parkinson’s disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase thatstimulates kinase activity
- 1 October 2007
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 313 (16), 3658-3670
- https://doi.org/10.1016/j.yexcr.2007.07.007
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicityHuman Molecular Genetics, 2007
- Leucine-rich repeat kinase 2: Relevance to Parkinson's diseaseThe International Journal of Biochemistry & Cell Biology, 2006
- LRRK2 protein is a component of lewy bodiesAnnals of Neurology, 2006
- LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?Trends in Molecular Medicine, 2006
- Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*Brain, 2005
- Lrrk2 pathogenic substitutions in Parkinson's diseaseneurogenetics, 2005
- Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's DiseaseNeuron, 2004
- RhoGDI-binding-defective mutant of Cdc42Hs targets to membranes and activates filopodia formation but does not cycle with the cytosol of mammalian cellsBiochemical Journal, 2001
- Intracellular trafficking and turnover of phosphatidylinositol 3-phosphateSeminars in Cell & Developmental Biology, 2001
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988